Suspected plague outbreak in Russia: public health risk lower than Covid-19
Despite concern, Y. pestis has a lower rate of transmission than coronavirus, as well being a more studied pathogen.
Comment & Opinion
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis
EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis
EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D
China expands its manufacturing role for biopharma’s new drugs
FDA hearing: psychedelics launch needs balanced regulation without limiting access
Looking beyond short-term turmoil, Syngene is investing for the future
